New Members Join the Corporate Roundtable

June 13, 2008

Share:

Sepracor, Inc., has just joined as a new Corporate Roundtable member. This company has now become a part the growing relationship between the AAN, the AAN Foundation, and industry, to meet the Foundation goals of promoting research and education, as well as improving the quality of care for patients with neurological disorders. This company joins the 26 other companies already a part of the Corporate Roundtable:

Allergan, Inc. Genzyme Oncology
AstraZeneca Pharmaceuticals, Inc. Medtronic, Inc.
Bayer Pharmaceuticals, Inc. Merck & Co., Inc.
Biogen Idec Myriad Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Novartis Pharmaceuticals, Inc.
Cardinal Health "Formerly Viasys" Orasi Medical, Inc.
Eisai Inc. Ortho McNeil Neurologics, Inc.
Eli Lilly and Company Pfizer, Inc.
EMD Serono, Inc. PhotoThera, Inc.
Endo Pharmaceuticals, Inc. Questcor Pharmaceuticals, Inc.
Forest Pharmaceuticals, Inc. TEVA Neuroscience
Genentech, Inc. UCB, Inc.
Genzyme Corporation Valeant Pharmaceuticals, Inc.

For more information

Find out more about the AAN Foundation's important work. Contact Alberta Zais (Associate Director, Corporate Relations) at azais@aan.com, (651) 695-2760; Bridget Farley (Exhibits and Corporate Relations Manager) at bfarley@aan.com, (651) 695-2703; or Kathie Lazar-Robinson (Administrative Assistant) at klazarrobinson@aan.com, (651) 695-2818, to find out how you can be part of the Academy's important research initiatives.